ETHZilla Corporation Warrant (ATNFW)
ETHZilla Corporation Warrant operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Palo Alto, DE, US. The stock last traded at $0.43, down 6.52% on the session, giving a market capitalisation of $2.6M. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -18427.2%. Its beta of 0.41 implies it has historically moved less than the broad market.
180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to pioneering novel pharmaceutical treatments that address significant unmet medical needs in areas such as inflammatory conditions, fibrotic disorders, and pain management. This research and development effort is powered by the collective expertise of distinguished therapeutics specialists from Oxford University, the Hebrew University, and Stanford University. The company was co-founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016, and maintains its principal office in Palo Alto, California.
ETHZilla Corporation Warrant is most often compared with the following Healthcare names: